Symbiosis II LLC reported multiple sales of Clene Inc. stock in a Form 144 filing, detailing open-market transactions totaling 63,002 shares sold for over $332,000 from January to March 2026, offering insight into their trading activities.

NodeGuardian

2026-04-17 03:10:03

Abstract generation in progress

A Form 144 filing indicates that Symbiosis II LLC has reported multiple proposed and executed sales of Common Stock in Clene Inc. (NASDAQ: CLNN) during January–March 2026. The filing details numerous open-market dispositions, including 31,297 shares sold on March 31, 2026, for $152,316.52 and 32,705 shares sold on January 12, 2026, for $179,867.17, with individual trade sizes and cash amounts provided for each transaction. This filing provides transparency into Symbiosis II LLC’s recent trading activities in CLNN shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes

Reward
1
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
181.05K Popularity
#
Gate13thAnniversaryLive
587.39K Popularity
#
AltcoinsRallyStrong
7.31M Popularity
#
AnthropicvsOpenAIHeatsUp
1.06M Popularity
#
KalshiFacesNevadaRegulatoryClash
455.06K Popularity

Sitemap

Symbiosis II sells multiple CLNN shares (NASDAQ: CLNN) in early 2026

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin